Compounding is a pharmacy practice, not an approval category. It can meet a patient-specific need in defined circumstances, but the finished compounded drug has not passed FDA’s new-drug approval review.
What does “not FDA approved” mean here?
FDA’s compounded-drug risk overview states that the agency does not verify compounded drugs’ safety, effectiveness or quality before they are marketed. Labels and promotional pages should not present a compounded product as FDA approved.
That distinction does not mean every compounded drug is unlawful or necessarily poor quality. It means consumers should not transfer the evidence and approval status of a named approved product to a compounded preparation.
What GLP-1-specific concerns has FDA raised?
FDA’s current unapproved GLP-1 page describes reports of dosing errors with compounded injectable semaglutide and concerns about salt forms such as semaglutide sodium and semaglutide acetate. It also discusses misleading marketing and shipping or storage issues.
The FDA says compounded drugs should be used only when an FDA-approved drug cannot meet a patient’s medical needs. The agency has determined the US shortages of semaglutide and tirzepatide injection products are resolved and, in its April 2026 clarification, reminded compounders that patient-specific and anti-copying conditions still apply. A seller’s general reference to an earlier shortage is not enough to establish that a particular product is lawful or appropriate now.
Do not translate those alerts into a self-directed dose change. Ask the prescriber and dispensing pharmacist to explain the exact product, concentration, units, device and instructions.
Which questions should I ask?
Before paying or using the product, ask:
- Why is a compounded product being proposed for this patient?
- What exact active ingredient and chemical form appears on the prescription?
- Which licensed pharmacy will compound and dispense it?
- What is the concentration, prescribed amount and measurement unit?
- Which syringe or device is intended, and who demonstrates its use?
- How should it be shipped, stored and checked on arrival?
- Who handles adverse effects, errors or a change in supply?
Verify the pharmacy through the relevant state board rather than relying on a badge shown by the seller.
Why are units and concentration important?
FDA has described reports involving patients measuring an incorrect amount and confusion among milligrams, millilitres and “units.” Concentrations can vary. Never infer instructions from a different product, vial or online video.
What can this guide not do?
It cannot determine whether compounding is legally or clinically appropriate, validate a pharmacy’s preparation, choose a dose, or interpret a symptom. Those tasks require qualified professionals and product-specific information. This article has not been reviewed by a clinician or pharmacist.